News

Filter

Current filters:

Tiagabine Hydrochloride

1 to 9 of 33 results

Cephalon agrees to pay $425M to resolve off-label marketing allegations

06-10-2008

The US Justice Department has announced that biopharmaceuticals firm Cephalon will enter a criminal plea…

ActiqCephalonFentanyl CitrateGabitrilModafinilNystatinOralProvigilTiagabine Hydrochloride

Cephalon exceeds guidance for 2nd qtr

11-08-2008

US drugmaker Cephalon exceeded its earnings guidance for the second quarter of 2008, moving into profit…

ActiqAmrixbendamustineCephalonCyclobenzaprine HCl Extended-Release CapsulesFentanyl Buccal TabletFentanyl CitrateFentoraGabitrilModafinilNystatinOralProvigilTiagabine HydrochlorideTreanda

Cephalon's full-year 2005 loss deepens 130%

27-02-2006

Cephalon says that its 2005 loss worsened 130% year-on-year to $175.0 million, or $3.01 a share, due…

ActiqCephalonFentanyl CitrateGabitrilModafinilNystatinOralProvigilTiagabine Hydrochloride

Cephalon post record results for 2004

28-02-2005

According to US biotechnology major Cephalon, its financial results for 2004 exceeded independent market…

ActiqCephalonFentanyl CitrateGabitrilModafinilNystatinOralProvigilTiagabine Hydrochloride

Cephalon's 3rd-qtr loss grows on charges

15-11-2004

Cephalon has reported a 38% leap in third-quarter 2004 sales to $262.0 million, driven by a strong performance…

ActiqCephalonFentanyl CitrateGabitrilModafinilNystatinOralProvigilTiagabine Hydrochloride

Cephalon's 1st-qtr sales up 49% to $215M

10-05-2004

The USA's Cephalon has seen its first-quarter revenue jump 49% to $215.0 million from $144.7 million…

ActiqCephalonFentanyl CitrateGabitrilModafinilNystatinOralProvigilTiagabine Hydrochloride

1 to 9 of 33 results

COMPANY SPOTLIGHT

Menarini

Back to top